PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal cancer |
| Phenotype | C0015230|rash |
| Sentences | 4 |
| PubMedID- 24332355 | Pilot clinical trial on the efficacy of prophylactic use of vitamin k1-based cream (vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer. |
| PubMedID- 23855804 | Interestingly, almost all studies addressing egfr-inhibitor-induced skin rash done in patients with metastatic colorectal cancer suggest that its severity is a suitable surrogate marker for efficacy of anti-egfr therapy [44-47]. |
| PubMedID- 23321777 | The objective of this review is to assess the predictive value of skin rash in patients with advanced colorectal cancer treated with cetuximab and panitumumab. |
| PubMedID- 23238388 | Conclusions: the prophylactic application of topical vitamin k1 cream did not translate into clinically meaningful benefit in terms of reducing acneiform rash in patients with metastatic colorectal cancer treated with cetuximab. |
Page: 1